my cart
  • log-in
  • applications / products

    Applications

    • Drug Discovery & Development
    • Cell Banks for Bioassays
    • Potency & QC Lot Release
    • Detect Neutralizing Abs
    • Cytotoxicity Assays
    • Target Engagement
    • Translocation Assays
    • Targeted Protein Degradation
    • Signaling Pathway Reporters
    • Pharmacotrafficking Assays
    • Do-It-Yourself Assays
    • Therapeutic/Disease Area
    • Custom Development Capabilities

    Products

    • Cells & Cell Lines
    • Assay Ready Kits
    • Bioassay Kits
    • eXpress Kits
    • Frozen Cells
    • Membrane Preps
    • Proteins & Kinases
    • Cell Culture Reagents
    • Detection Reagents
    • Biochemical Assays
    • Control Ligands & Inhibitors
  • targets
    • A-Z List of Target List
    • GPCRs
    • Kinases
    • Checkpoint Receptors
    • Ion Channels
    • Cytokines & Interleukins
    • Signaling Pathways
    • Nuclear Proteins
    • Epigenetics Proteins
  • technologies / platforms
    • Enzyme Fragment Complementation
    • Human Primary Cell Screening
    • Competition Binding Platform
  • tools / resources

    Document Resource Library

    • Flyers & Brochure
    • User Manuals & Protocols
    • White Papers & Applications
    • Scientific Posters
    • Presentations

    Webinars

    Knowledge-Based Videos

    Blogs

    Publications & References

    CRO Certification

    Reagent Calculators

    Instrument Compatibility

  • services
  • Contact Us
    • Customer & Technical Support
    • Submit an Order
    • Technical Resources
    • Literature & Email Signup
    • Legal & Policies
    • Locations
    • Distributors
    • Procurement Partners
  • about us
    • Company
    • Contact Us
    • Careers
    • Announcements
    • Events
Search Product
Contact a Specialist
PathHunter® Jurkat CD47-Presenting Cell Line

/products/cell-line/jurkat-cd47-presenting-cell-line-93-1149c19
Anti-CD47 antibody

/products/reagent/anti-cd47-antibody-92-1341
[CD47/SIRPa Summit 2020] A Novel MOA-reflective Bioassay for Quantifying Potency of Therapeutics Targeting the SIRPα|CD47 Signaling Axis
Watch Recorded Presentation Jane Lamerdin, Ph.D. Director R&D, Eurofins DiscoverX
/tools-resources/document-resource-library/documents/bioassay-presentation-cd47-summit-2020 11/16/2020 4:35:24 PM
Checkpoint Receptors
Applications Assay Principle Assay Highlights Advantages of Checkpoint Assays PathHunter checkpoint assays are MOA-reflective assays for quantifying a functional response as a result of direct ligand binding to its checkpoint receptor.  These cell-based assays enable rapid s...
/targets/checkpoint-assays 4/29/2020 4:06:29 PM
[BEBPA NA 2020] Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have pr...
/tools-resources/document-resource-library/documents/bebpa-na-2020-checkpoint-poster 3/23/2020 3:06:54 PM
[Advances in Immuno-Oncology Congress] Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have p...
/tools-resources/document-resource-library/documents/adv-io-congress-checkpoints-poster 8/6/2020 5:05:46 PM
[PEGS 2021] Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have prove...
/tools-resources/document-resource-library/documents/pegs-2021-novel,-improved-cell-based-assays-to-e 5/19/2021 10:55:43 PM
[Immuno-Oncology Summit 2021] Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have prov...
/tools-resources/document-resource-library/documents/novel-improved-cell-based-assays-to-enable 10/12/2021 12:01:04 AM
[DOT 2021] Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have pr...
/tools-resources/document-resource-library/documents/dot-2021-novel,-improved-cell-based-assays-to-en 10/14/2021 3:32:15 PM
[Immuno-Oncology Summit 2020] Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors
Regulation of immune responses is tightly controlled through a balance of co-stimulatory and inhibitory checkpoint receptors, often exploited by many cancers. Therefore, therapeutics that block inhibitory receptors or activate immuno-stimulatory checkpoint receptors have p...
/tools-resources/document-resource-library/documents/checkpoint-poster-iosummit-2020 10/6/2020 5:17:43 PM
|<  <   1 2    >  >| Pages: 1 of 2
+ sitemap © 2020 Eurofins DiscoverX Products. All rights reserved.
  • Contact Us
  • Legal & Privacy
  • Cookie Notice